selegiline

(redirected from Seligiline)
Also found in: Medical.
Related to Seligiline: amantadine, Madopar

se·leg·i·line

 (sə-lĕj′ə-lēn′)
n.
A selective monoamine oxidase inhibitor, C13H17N, used transdermally as an antidepressant and in its hydrochloride form in conjunction with levodopa and carbidopa to treat patients with Parkinson's disease.

[Probably sele(ctive) (from its being a selective monoamine oxidase inhibitor) + alteration of (par)gyline, a closely related drug (ultimately from Latin arg(entum), silver; see arg- in Indo-European roots from the fact that one of the constituents of pargyline was discovered in a precipitate containing silver + -yl + -ine).]

selegiline

(səˈlɛɡɪˌliːn)
n
(Medicine) a drug used in treating Parkinson's disease, depression and dementia
Translations

selegiline

n selegilina
References in periodicals archive ?
They are given melatonin, growth and sex hormones as well as "non-hormonal performance-enhancing drugs" such as the seligiline hydro-chloride used to treat Parkinson's disease, and centrophenoxine, used to increase cerebral circulation.
Specifically, alpha-tocopherol (a form of vitamin E) and a drug called seligiline were found to slow down some symptoms of Alzheimer's disease by about seven months.
The present study examines two other agents, seligiline and alpha-tocopherol, which have been reported to either slow or reduce neuronal damage in other conditions.